Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.45 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.70 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.26.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.108 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.32 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.37 (Lambda)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.15 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.375EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.79.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.440EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.104 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used